Last €2.97 EUR
Change Today -0.159 / -5.08%
Volume 0.0
RN3 On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:17 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven W. Spector J.D.

Executive Vice President, General Counsel and Secretary, Arena Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$2,297,604
As of Fiscal Year 2013

Background*

Mr. Steven W. Spector, JD has been General Counsel and secretary at Arena Pharmaceuticals, Inc. since October 2001 and November 2001 respectively and serves as its Executive Vice President. Mr. Spector served as Senior Vice President since of Arena Pharmaceuticals, Inc. He served as Vice President of Arena Pharmaceuticals Inc. from October 2001 to June 2004. Prior to joining Arena Pharmaceuticals Inc., Mr. Spector was a partner with the law firm of Morgan, Lewis & Bockius ...

Read Full Background

Corporate Headquarters*

6154 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-453-7200
Fax: 858-453-7210

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD
The University of Pennsylvania
BA
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Salary$395,000
Total Annual Compensation$395,000

Stock Options*

Restricted Stock Awards$1,290,600
All Other Compensation$16,041
Exercised Options40,000
Exercised Options Value$174,836
Exercisable Options523,335
Exercisable Options Value$933,002
Unexercisable Options725,000
Unexercisable Options Value$2,267,000
Total Value of Options$3,374,837
Total Number of Options1,288,335

Total Compensation*

Total Annual Cash Compensation$614,714
Total Short Term Compensation$395,000
Other Long Term Compensation$1,306,641
Total Calculated Compensation$2,297,604
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RN3:GR €2.97 EUR -0.159

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Raul R. Rodriguez Chief Executive Officer, President and Director
Rigel Pharmaceuticals, Inc.
$551.7K
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$1.8M
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.